When evaluating AVAX for long-term investments, the blue support zone highlighted on the chart stands out as the key area to monitor for potential spot entries. If AVAX closes daily candles below the $22.77 level, it is expected to continue its downward trend.
The primary spot buy zone for AVAX is identified between the $21.20 – $20.25 support range. If the price retraces into the blue zone on the chart, we plan to initiate spot positions. Should AVAX show a reversal from this area, our next upside targets are $27.63 and $32, respectively.
If AVAX fails to generate a strong reaction from the blue zone and continues to decline, we will then monitor the $18 support level. As long as AVAX holds above $18, our bullish outlook from this analysis remains valid.
Not Financial Advice (NFA).
The primary spot buy zone for AVAX is identified between the $21.20 – $20.25 support range. If the price retraces into the blue zone on the chart, we plan to initiate spot positions. Should AVAX show a reversal from this area, our next upside targets are $27.63 and $32, respectively.
If AVAX fails to generate a strong reaction from the blue zone and continues to decline, we will then monitor the $18 support level. As long as AVAX holds above $18, our bullish outlook from this analysis remains valid.
Not Financial Advice (NFA).
Trade active
#AVAX Daily UpdateAVAX fell to the support zone of $21.20 and $20.25, as we mentioned in our previous analysis. We made our first spot investment at the $21.20 level.
Additionally, we moved our buy order at the second spot buy level of $20.25 to the $19.20 level. As a result, our next spot buy order is now at the $19.20 level.
If AVAX performs a wick movement to the $19.20 level, we will include it in our spot portfolio through partial purchases. Our first upward expectation for AVAX is for it to reclaim the $22.77 support zone. NFA.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.